With the new $94 million (€90 million) funding, the company will develop its pipeline of oral macrocycle drugs, nCycles, against validated biologic targets.

Science laboratory test tubes , laboratory equipment | Image Credit: © BillionPhotos.com - stock.adobe.com

Recipharm Investment Will Enhance Oral Solid Development, GMP Pilot-Scale Suites

By Patrick Lavery

September 17th 2024

The company said this new commitment to its facility in Germany goes hand in hand with its recently announced ReciPredict, an initiative intended to streamline the product development cycle.

making white capsules. compounding pharmacy. compounding green medication. | Image Credit: © J. Balla Photography - © J. Balla Photography - stock.adobe.com

Compounding Overview: Primary Considerations for the Workplace

By Paul L. Pluta

February 3rd 2024

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.

Mock-up cosmetic tubes, bottle with spilled tablets and syringes with ampules on white, orange and blue background. Cosmetology vs medicine concept. Flat lay.|Image Credit: © LanaUst - © LanaUst - stock.adobe.com

Driving Dosage Form Developments

By Felicity Thomas

September 29th 2023

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

Africa Studio/Stock.adobe.com – Variances and means are compared using F and T tests, respectively.

Justification of Using Weight Variation Instead of Content Uniformity for Release of Relevant OSD Forms

By Pramote Cholayudth

March 3rd 2023

This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.

<1 2 3

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777